por
John R. Fischer, Senior Reporter | January 20, 2022
The updated USPSTF 2021 lung cancer screening guidelines reduced racial disparities in access
In addition to opening up eligibility, the USPSTF 2021 update for lung cancer screening decreased racial disparities in access to care.
The revised guidelines
dropped the starting age to screen adults from 55 to 50 and redefined eligibility from a 30 pack-year smoking history to a 20 pack-year history. Adults who are either currently smoking or quit within the past 15 years are eligible. The changes were recommended last March, with CMS
adopting them officially in November.
With the 2013 USPSTF criteria, a 10% higher number of white patients than African Americans were eligible to be screened. The 2021 update reduced this difference to 2%, wrote U.S. researchers in a retrospective analysis,
according to Physician’s Weekly.
Ad Statistics
Times Displayed: 16169
Times Visited: 33 Final days to save an extra 10% on Imaging, Ultrasound, and Biomed parts web prices.* Unlimited use now through September 30 with code AANIV10 (*certain restrictions apply)
While African American patients often have a lower smoking pack-year history, they are at the same at higher risk for lung cancer compared to white people and are also at risk at a younger age. “Broader fixed criteria and the use of predictive model risk-based criteria have been proposed as an approach to better include those at high risk and address racial disparities in eligibility,” wrote the authors.
Participants were recruited from the Inflammation, Health, Ancestry, and Lung Epidemiology study and were from the Detroit metropolitan area. All were compared to volunteer controls and were between 21 and 89. Each had an interview and underwent low-dose chest CT and pulmonary function tests. A total of 912 had lung cancer, with 54% being women, and were compared to 1,457 controls without lung cancer at enrollment.
In addition to the 2013 recommendations, the authors compared the sensitivity and specificity of the 2021 USPSTF guidelines to that of the 2012 update for the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial (PLCOm2012) and the National Comprehensive Cancer Network (NCCN) group 2 criteria in a real-world setting.
Under the 2013 criteria, 324 of 625 (52%) white patients were eligible for screening versus 121 of 287 (42%) African American ones. Under 2021 recommendations, 408 of 625 (65%) white patients were able to get screened and 192 of 287 (63%) African American patients were able to as well. With the PLCOm2012 criteria, the disparity was even smaller, at 427 of 625 (68%) white patients versus 192 of 287 (67%) African American patients.
